RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: intestinal schistosomiasis
Accession: DOID:0050597
browse the term
Definition: A schistosomiasis that involves parasitic infection of the intestine caused by Schistosoma mansoni, Schistosoma intercalatum or Schistosomiasis japonicum. The symptoms include fever, cough, abdominal pain, diarrhea, hepatosplenomegaly, colonic polyposis with bloody diarrhea and eosinophilia. (DO)
Synonyms: exact_synonym: intestinal schistosomiases
xref: EFO:1001419 ; ICD10CM:B65.1 ; ICD10CM:B65.2 ; ICD9CM:120.1 ; ICD9CM:120.2 ; NCI:C35364 ; ORDO:1247
Please select species to view GViewer data.
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
G
CD1D
CD1d molecule
treatment
ISO
RGD
PMID:33283278
RGD:127345110
NCBI chr20:5,726,307...5,733,355
Ensembl chr20:5,727,049...5,730,061
G
D
CD1D
CD1d molecule
treatment
ISO
RGD
PMID:33283278
RGD:127345110
NCBI chr38:23,489,169...23,491,712
G
B
CD1D
CD1d molecule
treatment
ISO
RGD
PMID:33283278
RGD:127345110
NCBI chr 1:133,549,258...133,557,752
Ensembl chr 1:137,341,690...137,348,173
G
H
CD1D
CD1d molecule
treatment
ISO
RGD
PMID:33283278
RGD:127345110
NCBI chr 1:158,178,030...158,186,427
Ensembl chr 1:158,178,030...158,186,427
G
R
Cd1d1
CD1d1 molecule
treatment
ISO
RGD
PMID:33283278
RGD:127345110
NCBI chr 2:174,721,522...174,725,029
Ensembl chr 2:172,423,582...172,427,089
G
M
Cd1d1
CD1d1 antigen
treatment
IMP
RGD
PMID:33283278
RGD:127345110
NCBI chr 3:86,903,141...86,919,665
Ensembl chr 3:86,903,141...86,906,748
G
M
H2-Aa
histocompatibility 2, class II antigen A, alpha
susceptibility
ISO
DNA:polymorphisms: :
RGD
PMID:16042197
RGD:14398841
NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797
G
H
HLA-DQA1
major histocompatibility complex, class II, DQ alpha 1
susceptibility
IAGP
DNA:polymorphisms: :
RGD
PMID:16042197
RGD:14398841
NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062
G
N
Il18
interleukin 18
treatment
ISO
RGD
PMID:19467215
RGD:14696662
NCBI chrNW_004624784:7,294,286...7,312,959
Ensembl chrNW_004624784:7,294,183...7,304,687
G
G
IL18
interleukin 18
treatment
ISO
RGD
PMID:19467215
RGD:14696662
NCBI chr 1:103,485,868...103,511,632
Ensembl chr 1:103,482,083...103,510,150
G
P
IL18
interleukin 18
treatment
ISO
RGD
PMID:19467215
RGD:14696662
NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219
G
S
Il18
interleukin 18
treatment
ISO
RGD
PMID:19467215
RGD:14696662
NCBI chrNW_004936612:2,306,963...2,325,086
Ensembl chrNW_004936612:2,306,875...2,325,189
G
D
IL18
interleukin 18
treatment
ISO
RGD
PMID:19467215
RGD:14696662
NCBI chr 5:20,972,742...20,995,327
Ensembl chr 5:20,972,871...20,995,348
G
B
IL18
interleukin 18
treatment
ISO
RGD
PMID:19467215
RGD:14696662
NCBI chr11:107,024,376...107,045,194
Ensembl chr11:110,867,586...110,888,371
G
C
Il18
interleukin 18
treatment
ISO
RGD
PMID:19467215
RGD:14696662
NCBI chrNW_004955412:13,807,361...13,826,007
Ensembl chrNW_004955412:13,806,553...13,825,634
G
R
Il18
interleukin 18
treatment
ISO
RGD
PMID:19467215
RGD:14696662
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887
G
M
Il18
interleukin 18
treatment
IDA
RGD
PMID:19467215
RGD:14696662
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
H
IL18
interleukin 18
treatment
ISO
RGD
PMID:19467215
RGD:14696662
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,251...112,164,096
G
N
Il33
interleukin 33
severity treatment
ISO
protein:increased expression:serum
RGD
PMID:22590860 PMID:25944738
RGD:39939027 RGD:40400890
NCBI chrNW_004624736:10,733,944...10,786,188
Ensembl chrNW_004624736:10,764,486...10,784,864
G
G
IL33
interleukin 33
severity treatment
ISO
protein:increased expression:serum
RGD
PMID:22590860 PMID:25944738
RGD:39939027 RGD:40400890
NCBI chr12:73,235,585...73,283,665
Ensembl chr12:73,237,406...73,252,436
G
P
IL33
interleukin 33
severity treatment
ISO
protein:increased expression:serum
RGD
PMID:22590860 PMID:25944738
RGD:39939027 RGD:40400890
NCBI chr 1:215,899,830...215,941,944
Ensembl chr 1:215,899,436...215,941,840
G
S
Il33
interleukin 33
severity treatment
ISO
protein:increased expression:serum
RGD
PMID:22590860 PMID:25944738
RGD:39939027 RGD:40400890
NCBI chrNW_004936539:763,755...791,461
Ensembl chrNW_004936539:623,248...791,470
G
D
IL33
interleukin 33
treatment severity
ISO
protein:increased expression:serum
RGD
PMID:22590860 PMID:25944738
RGD:39939027 RGD:40400890
NCBI chr11:27,219,878...27,256,723
Ensembl chr11:27,219,878...27,256,721
G
B
IL33
interleukin 33
treatment severity
ISO
protein:increased expression:serum
RGD
PMID:22590860 PMID:25944738
RGD:39939027 RGD:40400890
NCBI chr 9:6,027,014...6,069,540
Ensembl chr 9:6,234,178...6,248,624
G
C
Il33
interleukin 33
treatment severity
ISO
protein:increased expression:serum
RGD
PMID:22590860 PMID:25944738
RGD:39939027 RGD:40400890
NCBI chrNW_004955434:10,145,449...10,187,595
Ensembl chrNW_004955434:10,171,812...10,188,948
G
R
Il33
interleukin 33
treatment severity
ISO
protein:increased expression:serum
RGD
PMID:22590860 PMID:25944738 PMID:25944738
RGD:39939027 , RGD:40400890 , RGD:40400890
NCBI chr 1:237,115,478...237,149,897
Ensembl chr 1:227,721,435...227,736,373
G
M
Il33
interleukin 33
treatment severity
ISO IMP IDA
protein:increased expression:serum
RGD
PMID:22590860 PMID:25944738 PMID:25944738
RGD:39939027 , RGD:40400890 , RGD:40400890
NCBI chr19:29,902,513...29,938,118
Ensembl chr19:29,902,514...29,938,118
G
H
IL33
interleukin 33
treatment severity
IEP ISO
protein:increased expression:serum
RGD
PMID:22590860 PMID:25944738 PMID:25944738
RGD:39939027 , RGD:40400890 , RGD:40400890
NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,786...6,257,983
G
G
MHC-DQA1
major histocompatibility complex, class II, DQ alpha 1
susceptibility
ISO
DNA:polymorphisms: :
RGD
PMID:16042197
RGD:14398841
NCBI chr17:39,422,445...39,428,777
Ensembl chr17:39,420,134...39,428,871
G
D
MIR223
microRNA mir-223
treatment
ISO
RNA:increased expression:plasma:
RGD
PMID:24330517
RGD:21408589
NCBI chr X:50,838,131...50,838,233
Ensembl chr X:50,838,131...50,838,233
G
R
Mir223
microRNA 223
treatment
ISO
RNA:increased expression:plasma:
RGD
PMID:24330517 PMID:24330517
RGD:21408589 , RGD:21408589
NCBI chr X:65,151,383...65,151,492
Ensembl chr X:61,141,887...61,141,996
G
M
Mir223
microRNA 223
treatment
IEP ISO
RNA:increased expression:plasma:
RGD
PMID:24330517 PMID:24330517
RGD:21408589 , RGD:21408589
NCBI chr X:95,286,423...95,286,532
Ensembl chr X:95,286,423...95,286,532
G
H
MIR223
microRNA 223
treatment
ISO IEP
RNA:increased expression:plasma:
RGD
PMID:24330517 PMID:24330517
RGD:21408589 , RGD:21408589
NCBI chr X:66,018,870...66,018,979
Ensembl chr X:66,018,870...66,018,979
G
P
PCD1B
CD1B antigen
treatment
ISO
RGD
PMID:33283278
RGD:127345110
NCBI chr 4:92,035,122...92,040,724
Ensembl chr 4:92,031,712...92,040,742
G
N
Pdcd1
programmed cell death 1
severity
ISO
protein:increased expression:CD4 T cell
RGD
PMID:27792733
RGD:40818413
NCBI chrNW_004624847:5,732,922...5,741,908
Ensembl chrNW_004624847:5,732,767...5,742,269
G
G
PDCD1
programmed cell death 1
severity
ISO
protein:increased expression:CD4 T cell
RGD
PMID:27792733
RGD:40818413
NCBI chr10:127,877,383...127,886,234
Ensembl chr10:127,878,554...127,886,088
G
P
PDCD1
programmed cell death 1
severity
ISO
protein:increased expression:CD4 T cell
RGD
PMID:27792733
RGD:40818413
NCBI chr15:140,337,353...140,347,493
Ensembl chr15:140,336,258...140,347,478
G
S
Pdcd1
programmed cell death 1
severity
ISO
protein:increased expression:CD4 T cell
RGD
PMID:27792733
RGD:40818413
NCBI chrNW_004936745:152,571...163,712
Ensembl chrNW_004936745:152,612...161,587
G
D
PDCD1
programmed cell death 1
severity
ISO
protein:increased expression:CD4 T cell
RGD
PMID:27792733
RGD:40818413
NCBI chr25:51,606,559...51,618,903
Ensembl chr25:51,608,173...51,618,723
G
B
PDCD1
programmed cell death 1
severity
ISO
protein:increased expression:CD4 T cell
RGD
PMID:27792733
RGD:40818413
NCBI chr12:130,849,353...130,858,776
G
C
Pdcd1
programmed cell death 1
severity
ISO
protein:increased expression:CD4 T cell
RGD
PMID:27792733
RGD:40818413
NCBI chrNW_004955542:49,290...57,747
Ensembl chrNW_004955542:49,259...58,823
G
R
Pdcd1
programmed cell death 1
severity
ISO
protein:increased expression:CD4 T cell
RGD
PMID:27792733 PMID:27792733 PMID:27792733
RGD:40818413 , RGD:40818413 , RGD:40818413
NCBI chr 9:101,866,124...101,879,278
Ensembl chr 9:94,418,791...94,431,937
G
M
Pdcd1
programmed cell death 1
severity
ISO IMP IEP
protein:increased expression:CD4 T cell
RGD
PMID:27792733 PMID:27792733 PMID:27792733
RGD:40818413 , RGD:40818413 , RGD:40818413
NCBI chr 1:93,966,027...93,980,278
Ensembl chr 1:93,966,027...93,980,278
G
H
PDCD1
programmed cell death 1
severity
IEP ISO
protein:increased expression:CD4 T cell
RGD
PMID:27792733 PMID:27792733 PMID:27792733
RGD:40818413 , RGD:40818413 , RGD:40818413
NCBI chr 2:241,849,884...241,858,894
Ensembl chr 2:241,849,884...241,858,894
G
R
RT1-Ba
RT1 class II, locus Ba
susceptibility
ISO
DNA:polymorphisms: :
RGD
PMID:16042197
RGD:14398841
NCBI chr20:4,577,057...4,581,650
Ensembl chr20:4,575,134...4,579,744
G
N
Serpinh1
serpin family H member 1
ISO
mRNA,protein:increased expression:liver, serum (mouse)
RGD
PMID:31612672
RGD:41412161
NCBI chrNW_004624817:1,561,471...1,570,425
Ensembl chrNW_004624817:1,561,471...1,570,947
G
G
SERPINH1
serpin family H member 1
ISO
mRNA,protein:increased expression:liver, serum (mouse)
RGD
PMID:31612672
RGD:41412161
NCBI chr 1:66,787,978...66,798,930
Ensembl chr 1:66,788,240...66,799,072
G
P
SERPINH1
serpin family H member 1
ISO
mRNA,protein:increased expression:liver, serum (mouse)
RGD
PMID:31612672
RGD:41412161
NCBI chr 9:9,782,939...9,794,485
Ensembl chr 9:9,783,042...9,794,483
G
S
Serpinh1
serpin family H member 1
ISO
mRNA,protein:increased expression:liver, serum (mouse)
RGD
PMID:31612672
RGD:41412161
NCBI chrNW_004936498:4,341,944...4,351,432
Ensembl chrNW_004936498:4,341,899...4,351,524
G
D
SERPINH1
serpin family H member 1
ISO
mRNA,protein:increased expression:liver, serum (mouse)
RGD
PMID:31612672
RGD:41412161
NCBI chr21:23,032,761...23,041,649
Ensembl chr21:23,032,767...23,041,625
G
B
SERPINH1
serpin family H member 1
ISO
mRNA,protein:increased expression:liver, serum (mouse)
RGD
PMID:31612672
RGD:41412161
NCBI chr11:70,621,893...70,632,570
G
C
Serpinh1
serpin family H member 1
ISO
mRNA,protein:increased expression:liver, serum (mouse)
RGD
PMID:31612672
RGD:41412161
NCBI chrNW_004955414:16,284,845...16,292,828
Ensembl chrNW_004955414:16,284,845...16,292,963
G
R
Serpinh1
serpin family H member 1
ISO
mRNA,protein:increased expression:liver, serum (mouse)
RGD
PMID:31612672
RGD:41412161
NCBI chr 1:163,055,630...163,063,177
Ensembl chr 1:153,643,510...153,650,801
G
M
Serpinh1
serine (or cysteine) peptidase inhibitor, clade H, member 1
IEP
mRNA,protein:increased expression:liver, serum (mouse)
RGD
PMID:31612672
RGD:41412161
NCBI chr 7:98,994,583...99,002,321
Ensembl chr 7:98,994,583...99,002,446
G
H
SERPINH1
serpin family H member 1
ISO
mRNA,protein:increased expression:liver, serum (mouse)
RGD
PMID:31612672
RGD:41412161
NCBI chr11:75,562,253...75,572,783
Ensembl chr11:75,562,056...75,572,783
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
N
Aldh1a2
aldehyde dehydrogenase 1 family member A2
ISO
mRNA:increased expression:macrophage
RGD
PMID:22927819
RGD:14367882
NCBI chrNW_004624781:13,756,469...13,845,253
Ensembl chrNW_004624781:13,756,390...13,845,479
G
G
ALDH1A2
aldehyde dehydrogenase 1 family member A2
ISO
mRNA:increased expression:macrophage
RGD
PMID:22927819
RGD:14367882
NCBI chr26:25,439,159...25,557,199
Ensembl chr26:25,439,360...25,557,202
G
P
ALDH1A2
aldehyde dehydrogenase 1 family member A2
ISO
mRNA:increased expression:macrophage
RGD
PMID:22927819
RGD:14367882
NCBI chr 1:113,932,722...114,037,059
Ensembl chr 1:113,932,739...114,037,046
G
S
Aldh1a2
aldehyde dehydrogenase 1 family member A2
ISO
mRNA:increased expression:macrophage
RGD
PMID:22927819
RGD:14367882
NCBI chrNW_004936471:19,175,997...19,263,335
Ensembl chrNW_004936471:19,175,992...19,263,335
G
D
ALDH1A2
aldehyde dehydrogenase 1 family member A2
ISO
mRNA:increased expression:macrophage
RGD
PMID:22927819
RGD:14367882
NCBI chr30:23,074,432...23,170,374
Ensembl chr30:23,074,432...23,340,030
G
B
ALDH1A2
aldehyde dehydrogenase 1 family member A2
ISO
mRNA:increased expression:macrophage
RGD
PMID:22927819
RGD:14367882
NCBI chr15:36,925,443...37,038,288
Ensembl chr15:55,237,101...55,557,168
G
C
Aldh1a2
aldehyde dehydrogenase 1 family member A2
ISO
mRNA:increased expression:macrophage
RGD
PMID:22927819
RGD:14367882
NCBI chrNW_004955450:16,406,578...16,453,048
Ensembl chrNW_004955450:16,406,436...16,453,180
G
R
Aldh1a2
aldehyde dehydrogenase 1 family, member A2
ISO
mRNA:increased expression:macrophage
RGD
PMID:22927819
RGD:14367882
NCBI chr 8:80,758,641...80,837,891
Ensembl chr 8:71,877,850...71,957,107
G
M
Aldh1a2
aldehyde dehydrogenase family 1, subfamily A2
IEP
mRNA:increased expression:macrophage
RGD
PMID:22927819
RGD:14367882
NCBI chr 9:71,123,071...71,203,525
Ensembl chr 9:71,123,071...71,203,525
G
H
ALDH1A2
aldehyde dehydrogenase 1 family member A2
ISO
mRNA:increased expression:macrophage
RGD
PMID:22927819
RGD:14367882
NCBI chr15:57,953,429...58,065,711
Ensembl chr15:57,953,424...58,497,866
G
N
Cd40
CD40 molecule
treatment
ISO
RGD
PMID:10623823
RGD:11520789
NCBI chrNW_004624790:8,475,640...8,485,927
Ensembl chrNW_004624790:8,476,158...8,485,856
G
G
CD40
CD40 molecule
treatment
ISO
RGD
PMID:10623823
RGD:11520789
NCBI chr 2:17,753,713...17,765,134
Ensembl chr 2:17,753,394...17,764,566
G
P
CD40
CD40 molecule
treatment
ISO
RGD
PMID:10623823
RGD:11520789
NCBI chr17:48,286,116...48,298,188
Ensembl chr17:48,286,029...48,298,528
G
S
Cd40
CD40 molecule
treatment
ISO
RGD
PMID:10623823
RGD:11520789
NCBI chrNW_004936514:6,936,915...6,947,246
Ensembl chrNW_004936514:6,936,572...6,947,280
G
D
CD40
CD40 molecule
treatment
ISO
RGD
PMID:10623823
RGD:11520789
NCBI chr24:33,352,992...33,383,488
Ensembl chr24:33,372,930...33,383,301
G
B
CD40
CD40 molecule
treatment
ISO
RGD
PMID:10623823
RGD:11520789
NCBI chr20:42,455,711...42,467,139
Ensembl chr20:43,541,619...43,552,994
G
C
Cd40
CD40 molecule
treatment
ISO
RGD
PMID:10623823
RGD:11520789
NCBI chrNW_004955445:11,191,817...11,202,156
Ensembl chrNW_004955445:11,190,603...11,202,093
G
R
Cd40
CD40 molecule
treatment
ISO
RGD
PMID:10623823
RGD:11520789
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:153,790,449...153,805,534
G
M
Cd40
CD40 antigen
treatment
IMP
RGD
PMID:10623823
RGD:11520789
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
G
H
CD40
CD40 molecule
treatment
ISO
RGD
PMID:10623823
RGD:11520789
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
G
N
Cd86
CD86 molecule
ISO
protein:increased expression:peripheral blood, eosinophil (human)
RGD
PMID:17308795
RGD:11354987
NCBI chrNW_004624912:350,201...432,410
Ensembl chrNW_004624912:350,157...426,712
G
G
CD86
CD86 molecule
ISO
protein:increased expression:peripheral blood, eosinophil (human)
RGD
PMID:17308795
RGD:11354987
NCBI chr22:58,741,534...58,805,417
Ensembl chr22:58,741,525...58,805,366
G
P
CD86
CD86 molecule
ISO
protein:increased expression:peripheral blood, eosinophil (human)
RGD
PMID:17308795
RGD:11354987
NCBI chr13:138,427,573...138,504,307
Ensembl chr13:138,427,533...138,504,310
G
S
Cd86
CD86 molecule
ISO
protein:increased expression:peripheral blood, eosinophil (human)
RGD
PMID:17308795
RGD:11354987
NCBI chrNW_004936536:8,414,491...8,481,712
G
D
CD86
CD86 molecule
ISO
protein:increased expression:peripheral blood, eosinophil (human)
RGD
PMID:17308795
RGD:11354987
NCBI chr33:25,256,267...25,318,855
Ensembl chr33:25,256,267...25,318,087
G
B
CD86
CD86 molecule
ISO
protein:increased expression:peripheral blood, eosinophil (human)
RGD
PMID:17308795
RGD:11354987
NCBI chr 3:119,151,884...119,217,641
Ensembl chr 3:126,059,008...126,124,339
G
C
Cd86
CD86 molecule
ISO
protein:increased expression:peripheral blood, eosinophil (human)
RGD
PMID:17308795
RGD:11354987
NCBI chrNW_004955427:21,375,820...21,436,767
Ensembl chrNW_004955427:21,375,794...21,435,874
G
R
Cd86
CD86 molecule
ISO
protein:increased expression:peripheral blood, eosinophil (human)
RGD
PMID:17308795
RGD:11354987
NCBI chr11:77,647,565...77,706,178
Ensembl chr11:64,163,828...64,200,818
G
M
Cd86
CD86 antigen
ISO
protein:increased expression:peripheral blood, eosinophil (human)
RGD
PMID:17308795
RGD:11354987
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
G
H
CD86
CD86 molecule
IEP
protein:increased expression:peripheral blood, eosinophil (human)
RGD
PMID:17308795
RGD:11354987
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
G
N
Ihh
Indian hedgehog signaling molecule
ISO
RGD
PMID:23121638
RGD:12910981
NCBI chrNW_004624823:5,959,329...5,965,584
Ensembl chrNW_004624823:5,959,448...5,964,769
G
G
IHH
Indian hedgehog signaling molecule
ISO
RGD
PMID:23121638
RGD:12910981
NCBI chr10:104,960,296...104,966,596
Ensembl chr10:104,960,120...104,966,585
G
P
IHH
Indian hedgehog signaling molecule
ISO
RGD
PMID:23121638
RGD:12910981
NCBI chr15:121,083,750...121,090,548
Ensembl chr15:121,083,753...121,090,121
G
S
Ihh
Indian hedgehog signaling molecule
ISO
RGD
PMID:23121638
RGD:12910981
NCBI chrNW_004936569:1,474,693...1,480,562
Ensembl chrNW_004936569:1,474,665...1,480,568
G
D
IHH
Indian hedgehog signaling molecule
ISO
RGD
PMID:23121638
RGD:12910981
NCBI chr37:25,616,942...25,622,989
G
B
IHH
Indian hedgehog signaling molecule
ISO
RGD
PMID:23121638
RGD:12910981
NCBI chr2B:106,312,472...106,319,124
Ensembl chr2B:224,906,271...224,911,506
G
C
Ihh
Indian hedgehog signaling molecule
ISO
RGD
PMID:23121638
RGD:12910981
NCBI chrNW_004955453:14,376,665...14,382,536
Ensembl chrNW_004955453:14,376,718...14,381,747
G
R
Ihh
Indian hedgehog signaling molecule
ISO
RGD
PMID:23121638
RGD:12910981
NCBI chr 9:83,952,986...83,959,203
Ensembl chr 9:76,504,315...76,510,532
G
M
Ihh
Indian hedgehog
ISO
RGD
PMID:23121638
RGD:12910981
NCBI chr 1:74,984,474...74,990,831
Ensembl chr 1:74,984,474...74,990,831
G
H
IHH
Indian hedgehog signaling molecule
IEP
RGD
PMID:23121638
RGD:12910981
NCBI chr 2:219,054,424...219,060,921
Ensembl chr 2:219,054,424...219,060,921
G
N
Il13
interleukin 13
treatment
ISO
RGD
PMID:10903803
RGD:8549615
NCBI chrNW_004624733:39,427,189...39,430,019
Ensembl chrNW_004624733:39,428,095...39,429,843
G
G
IL13
interleukin 13
treatment
ISO
RGD
PMID:10903803
RGD:8549615
NCBI chr23:35,475,762...35,479,419
Ensembl chr23:35,476,490...35,478,869
G
P
IL13
interleukin 13
treatment
ISO
RGD
PMID:10903803
RGD:8549615
NCBI chr 2:134,972,099...134,976,672
Ensembl chr 2:134,972,623...134,975,093
G
S
Il13
interleukin 13
treatment
ISO
RGD
PMID:10903803
RGD:8549615
NCBI chrNW_004936647:2,529,933...2,532,503
Ensembl chrNW_004936647:2,530,491...2,532,373
G
D
IL13
interleukin 13
treatment
ISO
RGD
PMID:10903803
RGD:8549615
NCBI chr11:20,957,870...20,961,391
Ensembl chr11:20,958,464...20,961,388
G
B
IL13
interleukin 13
treatment
ISO
RGD
PMID:10903803
RGD:8549615
NCBI chr 5:128,073,863...128,078,453
Ensembl chr 5:134,235,788...134,240,548
G
C
Il13
interleukin 13
treatment
ISO
RGD
PMID:10903803
RGD:8549615
NCBI chrNW_004955408:4,046,406...4,049,795
G
R
Il13
interleukin 13
treatment
IMP
RGD
PMID:10903803
RGD:8549615
NCBI chr10:38,290,926...38,293,483
Ensembl chr10:37,790,130...37,792,737
G
M
Il13
interleukin 13
treatment
ISO
RGD
PMID:10903803
RGD:8549615
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
G
H
IL13
interleukin 13
treatment
ISO
RGD
PMID:10903803
RGD:8549615
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
G
N
Map3k8
mitogen-activated protein kinase kinase kinase 8
exacerbates
ISO
RGD
PMID:27487182
RGD:151356963
NCBI chrNW_004624805:2,611,297...2,633,650
Ensembl chrNW_004624805:2,611,038...2,633,943
G
G
MAP3K8
mitogen-activated protein kinase kinase kinase 8
exacerbates
ISO
RGD
PMID:27487182
RGD:151356963
G
P
MAP3K8
mitogen-activated protein kinase kinase kinase 8
exacerbates
ISO
RGD
PMID:27487182
RGD:151356963
NCBI chr10:40,714,004...40,746,390
Ensembl chr10:40,713,847...40,742,462
G
S
Map3k8
mitogen-activated protein kinase kinase kinase 8
exacerbates
ISO
RGD
PMID:27487182
RGD:151356963
NCBI chrNW_004936613:3,791,684...3,813,857
Ensembl chrNW_004936613:3,791,681...3,813,892
G
D
MAP3K8
mitogen-activated protein kinase kinase kinase 8
exacerbates
ISO
RGD
PMID:27487182
RGD:151356963
NCBI chr 2:16,717,845...16,740,816
Ensembl chr 2:16,720,596...16,740,515
G
B
MAP3K8
mitogen-activated protein kinase kinase kinase 8
exacerbates
ISO
RGD
PMID:27487182
RGD:151356963
NCBI chr10:30,579,220...30,607,249
Ensembl chr10:30,933,483...30,960,824
G
C
Map3k8
mitogen-activated protein kinase kinase kinase 8
exacerbates
ISO
RGD
PMID:27487182
RGD:151356963
NCBI chrNW_004955429:21,717,153...21,739,349
Ensembl chrNW_004955429:21,716,958...21,741,585
G
R
Map3k8
mitogen-activated protein kinase kinase kinase 8
exacerbates
ISO
RGD
PMID:27487182
RGD:151356963
NCBI chr17:58,078,175...58,098,455
Ensembl chr17:53,383,131...53,403,216
G
M
Map3k8
mitogen-activated protein kinase kinase kinase 8
exacerbates
IMP
RGD
PMID:27487182
RGD:151356963
NCBI chr18:4,331,325...4,352,978
Ensembl chr18:4,331,327...4,353,015
G
H
MAP3K8
mitogen-activated protein kinase kinase kinase 8
exacerbates
ISO
RGD
PMID:27487182
RGD:151356963
NCBI chr10:30,434,021...30,461,833
Ensembl chr10:30,434,021...30,461,833
G
N
Nos2
nitric oxide synthase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9673227
NCBI chrNW_004624786:491,944...530,427
Ensembl chrNW_004624786:489,311...528,271
G
G
NOS2
nitric oxide synthase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9673227
NCBI chr16:21,533,011...21,576,645
Ensembl chr16:21,533,484...21,574,257
G
P
NOS2
nitric oxide synthase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9673227
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
G
S
Nos2
nitric oxide synthase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9673227
NCBI chrNW_004936538:4,052,277...4,097,051
Ensembl chrNW_004936538:4,052,448...4,097,051
G
D
NOS2
nitric oxide synthase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9673227
NCBI chr 9:42,171,821...42,210,217
Ensembl chr 9:42,171,821...42,208,588
G
B
NOS2
nitric oxide synthase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9673227
NCBI chr17:28,984,295...29,021,516
Ensembl chr17:29,471,510...29,617,093
G
C
Nos2
nitric oxide synthase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9673227
NCBI chrNW_004955481:5,197,957...5,232,406
Ensembl chrNW_004955481:5,201,234...5,231,961
G
R
Nos2
nitric oxide synthase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9673227
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
M
Nos2
nitric oxide synthase 2, inducible
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9673227
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
H
NOS2
nitric oxide synthase 2
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:9673227
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
N
Sod1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16564582
NCBI chrNW_004624745:20,032,003...20,037,958
Ensembl chrNW_004624745:20,032,011...20,037,958
G
G
SOD1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16564582
NCBI chr 2:60,461,219...60,472,999
G
P
SOD1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16564582
NCBI chr13:195,326,573...195,335,273
Ensembl chr13:195,326,649...195,337,729
G
S
Sod1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16564582
NCBI chrNW_004936500:10,345,154...10,352,873
Ensembl chrNW_004936500:10,345,154...10,352,867
G
D
SOD1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16564582
NCBI chr31:26,540,291...26,544,212
Ensembl chr31:26,486,274...26,662,815
G
B
SOD1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16564582
NCBI chr21:18,029,831...18,037,526
G
C
Sod1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16564582
NCBI chrNW_004955407:31,261,451...31,267,657
Ensembl chrNW_004955407:31,263,863...31,267,727
G
R
Sod1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16564582
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
M
Sod1
superoxide dismutase 1, soluble
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16564582
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
G
H
SOD1
superoxide dismutase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16564582
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
G
P
TLR9
toll like receptor 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19797157
NCBI chr13:34,353,444...34,370,990
Ensembl chr13:34,349,609...34,357,673
G
D
TLR9
toll like receptor 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19797157
NCBI chr20:37,529,322...37,547,117
Ensembl chr20:37,542,340...37,547,114 Ensembl chr20:37,542,340...37,547,114
G
C
Tlr9
toll like receptor 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19797157
NCBI chrNW_004955532:3,828,645...3,832,699
Ensembl chrNW_004955532:3,828,775...3,832,582
G
R
Tlr9
toll-like receptor 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19797157
NCBI chr 8:115,743,407...115,747,523
Ensembl chr 8:106,864,680...106,868,796
G
M
Tlr9
toll-like receptor 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19797157
NCBI chr 9:106,099,797...106,104,075
Ensembl chr 9:106,099,797...106,104,082
G
H
TLR9
toll like receptor 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19797157
NCBI chr 3:52,221,080...52,225,645
Ensembl chr 3:52,221,080...52,225,645
G
G
TREM1
triggering receptor expressed on myeloid cells 1
ISO
RGD
PMID:21332515
RGD:126925988
NCBI chr17:30,873,647...30,885,292
Ensembl chr17:30,873,666...30,886,967
G
P
TREM1
triggering receptor expressed on myeloid cells 1
ISO
RGD
PMID:21332515
RGD:126925988
NCBI chr 7:36,510,253...36,531,796
Ensembl chr 7:36,510,253...36,531,796
G
S
Trem1
triggering receptor expressed on myeloid cells 1
ISO
RGD
PMID:21332515
RGD:126925988
NCBI chrNW_004936476:18,577,825...18,583,675
Ensembl chrNW_004936476:18,574,381...18,583,647
G
D
TREM1
triggering receptor expressed on myeloid cells 1
ISO
RGD
PMID:21332515
RGD:126925988
NCBI chr12:9,990,678...10,000,195
Ensembl chr12:9,990,679...10,000,236
G
B
TREM1
triggering receptor expressed on myeloid cells 1
ISO
RGD
PMID:21332515
RGD:126925988
NCBI chr 6:40,861,283...40,874,446
Ensembl chr 6:42,163,337...42,183,091
G
R
Trem1
triggering receptor expressed on myeloid cells 1
ISO
RGD
PMID:21332515
RGD:126925988
NCBI chr 9:20,259,227...20,276,879
Ensembl chr 9:12,763,819...12,779,203
G
M
Trem1
triggering receptor expressed on myeloid cells 1
IEP
RGD
PMID:21332515
RGD:126925988
NCBI chr17:48,539,763...48,553,955
Ensembl chr17:48,539,796...48,553,952
G
H
TREM1
triggering receptor expressed on myeloid cells 1
ISO
RGD
PMID:21332515
RGD:126925988
NCBI chr 6:41,267,385...41,286,682
Ensembl chr 6:41,267,100...41,286,682
G
G
TSLP
thymic stromal lymphopoietin
treatment
ISO
RGD
PMID:22882457
RGD:38596354
NCBI chr23:14,419,820...14,423,331
G
P
TSLP
thymic stromal lymphopoietin
treatment
ISO
RGD
PMID:22882457
RGD:38596354
NCBI chr 2:115,832,152...115,837,572
G
S
Tslp
thymic stromal lymphopoietin
treatment
ISO
RGD
PMID:22882457
RGD:38596354
NCBI chrNW_004936531:5,495,872...5,500,462
G
D
TSLP
thymic stromal lymphopoietin
treatment
ISO
RGD
PMID:22882457
RGD:38596354
NCBI chr 3:1,502,469...1,507,696
Ensembl chr 3:1,503,188...1,507,696
G
B
TSLP
thymic stromal lymphopoietin
treatment
ISO
RGD
PMID:22882457
RGD:38596354
NCBI chr 5:106,440,136...106,446,849
Ensembl chr 5:112,242,490...112,250,130
G
C
Tslp
thymic stromal lymphopoietin
treatment
ISO
RGD
PMID:22882457
RGD:38596354
NCBI chrNW_004955418:4,041,529...4,045,534
G
R
Tslp
thymic stromal lymphopoietin
treatment
ISO
RGD
PMID:22882457
RGD:38596354
NCBI chr18:24,723,990...24,728,419
Ensembl chr18:24,449,844...24,453,548
G
M
Tslp
thymic stromal lymphopoietin
treatment
IDA
RGD
PMID:22882457
RGD:38596354
NCBI chr18:32,948,436...32,952,852
Ensembl chr18:32,948,436...32,952,850
G
H
TSLP
thymic stromal lymphopoietin
treatment
ISO
RGD
PMID:22882457
RGD:38596354
NCBI chr 5:111,070,062...111,078,026
Ensembl chr 5:111,070,062...111,078,026
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all